CB Therapeutics
Growth Stage
Advanced synthetic biology for planet and human health
Overview
Raised: $0
Total Commitments ($USD)
Platform
Republic
Start Date
02/27/2023
Close Date
04/11/2023
Min. Goal
$25,000
Max. Goal
$1,235,000
Min. Investment
$250
Security Type
SAFE
Series
Series B
SEC Filing Type
RegCF
Valuation Cap
$45,000,000
Discount
20%
Rolling Commitments ($USD)
Status
Not Funded
Reporting Date
04/11/2023
Days Remaining
Not Funded
% of Min. Goal
Not Funded
% of Max. Goal
Not Funded
Likelihood of Max
Not Funded
Avg. Daily Raise
$0
Momentum
Not Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2015
Industry
Healthcare & Pharmaceuticals
Tech Sector
Biotech
Distribution Model
B2B
Margin
Medium
Capital Intensity
High
CB Therapeutics, with a valuation of $45 million, is raising funds on Republic. The company has developed an advanced synthetic biology and cellular agriculture platform. The platform aims to discover, develop, and produce compounds to solve problems in the field of healthcare, food, mental health, and the environment. CB Therapeutics has a substantial patent portfolio with seven granted and 13 pending patents and has been generating revenues since 2022. She Ali Butt and Jacob Vogan founded CB Therapeutics in March 2015. The current crowdfunding campaign has a minimum target of $25,000 and a maximum target of $1.24 million. The campaign proceeds will be used for small-scale manufacturing, hiring of laboratory personnel, and research and development.
Summary Profit and Loss Statement
| FY 2021 | FY 2020 | |
|---|---|---|
|
Revenue |
$2,014,066 |
$0 |
|
COGS |
$0 |
$0 |
|
Tax |
$3,017 |
$1,600 |
| ||
| ||
|
Net Income |
$-1,772,158 |
$-2,278,343 |
Summary Balance Sheet
| FY 2021 | FY 2020 | |
|---|---|---|
|
Cash |
$1,810,709 |
$13,453 |
|
Accounts Receivable |
$14,066 |
$0 |
|
Total Assets |
$3,722,376 |
$910,015 |
|
Short-Term Debt |
$287,110 |
$677,795 |
|
Long-Term Debt |
$188,555 |
$730,988 |
|
Total Liabilities |
$475,665 |
$1,408,783 |
Financials as of: 02/27/2023
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Already a member? Log in here.
Ratings 
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.